參考文獻/References:
[1] DAWSON A,DENNISON E.Measuring the musculoskeletal aging phenotype[J].Maturitas,2016,93:13-17.
[2] 馬遠征,王以朋,劉強,等.中國老年骨質(zhì)疏松癥診療指南(2018)[J].中國骨質(zhì)疏松雜志,2018,24(12):1541-1567.
[3] FIELDING R A,VELLAS B,EVANS W J,et al.Sarcopenia:an undiagnosed condition in older adults.Current consensus definition:prevalence,etiology,and consequences.International working group on sarcopenia[J].J Am Med Dir Assoc,2011,12(4):249-256.
[4] SZULC P,FEYT C,CHAPURLAT R.High risk of fall,poor physical function,and low grip strength in men with fracture—the STRAMBO study[J].J Cachexia Sarcopenia Muscle,2016,7(3):299-311.
[5] CHENG Q,ZHU X,ZHANG X,et al.A cross-sectional study of loss of muscle mass corresponding to sarcopenia in healthy Chinese men and women:reference values,prevalence,and association with bone mass[J].J Bone Miner Metab,2014,32(1):78-88.
[6] GO S W,CHA Y H,LEE J A,et al.Association between sarcopenia,bone density,and health-related quality of life in Korean men[J].Korean J Fam Med,2013,34(4):281-288.
[7] YOSHIMURA N,MURAKI S,OKA H,et al.Is osteoporosis a predictor for future sarcopenia or vice versa?Four-year observations between the second and third ROAD study surveys[J].Osteoporos Int,2017,28(1):189-199.
[8] PEREIRA F B,LEITE A F,DE PAULA A P.Relationship between pre-sarcopenia,sarcopenia and bone mineral density in elderly men[J].Arch Endocrinol Metab,2015,59(1):59-65.
[9] BINKLEY N,BUEHRING B.Beyond FRAX:it's time to consider “sarco-osteopenia”[J].J Clin Densitom,2009,12(4):413-416.
[10] BINKLEY N,KRUEGER D,BUEHRING B.What's in a name revisited:should osteoporosis and sarcopenia be considered components of “dysmobility syndrome?”[J].Osteoporos Int,2013,24(12):2955-2959.
[11] GIRGIS C M.Integrated therapies for osteoporosis and sarcopenia:from signaling pathways to clinical trials[J].Calcif Tissue Int,2015,96(3):243-255.
[12] BONEWALD L F,KIEL D,CLEMENS T,et al.Forum on bone and skeletal muscle interactions:summary of the proceedings of an ASBMR workshop[J].J Bone Mine Res,2013,28(9):1857-1865.
[13] FROST H M.Bone's mechanostat:A 2003 update[J].Anat Rec A Discov Mol Cell Evol Biol,2003,275A(2):1081-1101.
[14] QIN W P,SUN L,CAO J,et al.The central nervous system(CNS)-independent anti-bone-resorptive activity of muscle contraction and the underlying molecular and cellular signatures[J].J Biol Chem,2013,288(19):13511-13521.
[15] COLAIANNI G,CUSCITO C,MONGELLI T A,et al.The myokine irisin increases cortical bone mass[J].Proc Natl Acad Sci U S A,2015,112(39):12157-12162.
[16] 馬劍雄,匡明杰,何偉偉,等.肌肉減少癥與骨質(zhì)疏松的相關(guān)性:研究與應(yīng)用[J].中國組織工程研究,2018,22(32):5222-5227.
[17] KARSENTY G,OLSON E N.Bone and muscle endocrine functions:unexpected paradigms of inter-organ communication[J].Cell,2016,164(6):1248-1256.
[18] WANNENES F,PAPA V,GRECO E A,et al.Abdominal fat and sarcopenia in women significantly alter osteoblasts homeostasis in vitro by a WNT/β-catenin dependent mechanism[J].Int J Endocrinol,2014:278316
[19] YANG S Y,HOY M,FULLER B,et al.Pretreatment with insulin-like growth factor I protects skeletal muscle cells against oxidative damage via PI3K/Akt and ERK1/2 MAPK pathways[J].Lab Invest,2010,90(3):391-401.
[20] URANO T,INOUE S.Recent genetic discoveries in osteoporosis,sarcopenia and obesity[J].Endocr J,2015,62(6):475-484.
[21] 薛瑜,王鷗,邢小平.肌少癥篩查工具[J].中華骨質(zhì)疏松和骨礦鹽疾病雜志,2017,10(5):483-490.
[22] CRUZ-JENTOFT A J,BAHAT G,BAUER J,et al.Sarcopenia:revised European consensus on definition and diagnosis[J].Age Ageing,2019,48(1):16-31.
[23] CHEN L K,LIU L K,WOO J,et al.Sarcopenia in Asia:consensus report of the Asian working group for sarcopenia[J].J Am Med Dir Assoc,2014,15(2):95-101.
[24] 張智海,劉忠厚,李娜,等.中國人骨質(zhì)疏松癥診斷標準專家共識(第三稿·2014版)[J].中國骨質(zhì)疏松雜志,2014,20(9):1007-1010.
[25] MA X H,ZHANG W,WANG Y,et al.Comparison of the spine and hip bmd assessments derived from quantitative computed tomography[J].Int J Endocrinol,2015:675340.
[26] CRUZ-JENTOFT A J,LANDI F,SCHNEIDER S M,et al.Prevalence of and interventions for sarcopenia in ageing adults:a systematic review.Report of the International Sarcopenia Initiative(EWGSOP and IWGS)[J].Age Ageing,2014,43(6):748-759.
[27] PAHOR M,GURALNIK J M,AMBROSIUS W T,et al.Effect of structured physical activity on prevention of major mobility disability in older adults the life study randomized clinical trial[J].JAMA,2014,311(23):2387-2396.
[28] MORLEY J E,ARGILES J M,EVANS W J,et al.Nutritional recommendations for the management of sarcopenia[J].J Am Med Dir Assoc,2010,11(6):391-396.
[29] BEAUDART C,BUCKINX F,RABENDA V,et al.The effects of vitamin D on skeletal muscle strength,muscle mass,and muscle power:a systematic review and meta-analysis of randomized controlled trials[J].J Clin Endocrinol Metab,2014,99(11):4336-4345.
[30] MUIR S W,MONTERO-ODASSO M.Effect of vitamin D supplementation on muscle strength,gait and balance in older adults:a systematic review and Meta-Analysis[J].J Am Geriatr Soc,2011,59(12):2291-2300.
[31] MORLEY J E.Pharmacologic options for the treatment of sarcopenia[J].Calcif Tissue Int,2016,98(4):319-333.
[32] KOVACHEVA E L,HIKIM A P,SHEN R,et al.Testosterone supplementation reverses sarcopenia in aging through regulation of myostatin,c-Jun NH2-terminal kinase,Notch,and Akt signaling pathways[J].Endocrinology,2010,151(2):628-638.
[33] PAPANICOLAOU D A,ATHER S N,ZHU H,et al.A phase IIA randomized,placebo-controlled clinical trial to study the efficacy and safety of the selective androgen receptor modulator(SARM),MK-0773 in female participants with sarcopenia[J].J Nutr Health Aging,2013,17(6):533-543.
[34] WHITE H K,PETRIE C D,LANDSCHULZ W,et al.Effects of an oral growth hormone secretagogue in older adults[J].J Clin Endocrinol Metab,2009,94(4):1198-1206.
相似文獻/References:
[1]李林軍.應(yīng)用膨脹式椎弓根螺釘內(nèi)固定治療合并骨質(zhì)疏松的
胸腰椎退行性疾病[J].中醫(yī)正骨,2015,27(08):49.
[2]韓艷,溫利平,劉娜,等.補腎活血方對去卵巢大鼠骨代謝及骨密度的影響[J].中醫(yī)正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(補腎活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):7.
[3]李學(xué)朋,朱立國.骨疏康膠囊對去卵巢大鼠骨小梁的影響[J].中醫(yī)正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康膠囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(05):12.
[4]陳冠軍,陳揚,莊汝杰.可灌注骨水泥椎弓根螺釘系統(tǒng)
在老年腰椎疾患手術(shù)中的應(yīng)用[J].中醫(yī)正骨,2015,27(02):40.
[5]王丹輝,賁越,韓梅.林蛙油治療絕經(jīng)后骨質(zhì)疏松癥的臨床研究[J].中醫(yī)正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(05):27.
[6]黃建華,黃建武,李慧輝,等.加味左歸丸對絕經(jīng)后骨質(zhì)疏松癥肝腎不足證
患者骨密度的影響[J].中醫(yī)正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(05):19.
[7]項旻,楊虹,林愛菊,等.絕經(jīng)后2型糖尿病患者骨質(zhì)疏松與血微量元素的關(guān)系研究[J].中醫(yī)正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(05):20.
[8]史曉林,李春雯,張志強.弱陽離子磁珠分離技術(shù)和基質(zhì)輔助激光解吸電離飛行時間質(zhì)譜技術(shù)在原發(fā)性Ⅰ型骨質(zhì)疏松癥血清標志蛋白篩選中的應(yīng)用[J].中醫(yī)正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(05):5.
[9]李明,徐明雄,馮左基,等.自擬壯骨方治療絕經(jīng)后骨質(zhì)疏松癥的療效及作用機制研究[J].中醫(yī)正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(05):21.
[10]陳俊杰,李晴晴,夏瑢.脂代謝及血清內(nèi)脂素水平與絕經(jīng)后骨質(zhì)疏松癥的
相關(guān)性研究[J].中醫(yī)正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(05):16.